Your browser is no longer supported. Please, upgrade your browser.
GSK GlaxoSmithKline plc daily Stock Chart
GlaxoSmithKline plc
Index- P/E25.99 EPS (ttm)1.55 Insider Own0.20% Shs Outstand2.46B Perf Week-2.32%
Market Cap99.21B Forward P/E13.56 EPS next Y2.98 Insider Trans0.00% Shs Float2.46B Perf Month1.84%
Income3.84B PEG2.95 EPS next Q0.67 Inst Own11.40% Short Float0.31% Perf Quarter-2.40%
Sales39.53B P/S2.51 EPS this Y184.00% Inst Trans-0.34% Short Ratio3.05 Perf Half Y0.72%
Book/sh2.38 P/B16.95 EPS next Y1.19% ROA3.30% Target Price44.30 Perf Year14.63%
Cash/sh2.06 P/C19.61 EPS next 5Y8.80% ROE92.90% 52W Range34.52 - 42.36 Perf YTD13.73%
Dividend1.98 P/FCF53.87 EPS past 5Y-10.10% ROI22.90% 52W High-4.77% Beta0.79
Dividend %4.91% Quick Ratio0.60 Sales past 5Y2.70% Gross Margin68.80% 52W Low16.86% ATR0.79
Employees98462 Current Ratio0.90 Sales Q/Q3.20% Oper. Margin14.90% RSI (14)51.30 Volatility1.18% 1.63%
OptionableYes Debt/Eq6.19 EPS Q/Q16.10% Profit Margin6.20% Rel Volume1.44 Prev Close40.41
ShortableYes LT Debt/Eq5.54 EarningsOct 31 Payout161.80% Avg Volume2.48M Price40.34
Recom2.50 SMA200.39% SMA501.20% SMA2001.63% Volume3,574,702 Change-0.17%
Oct-09-18Initiated Guggenheim Neutral
Aug-30-18Downgrade Liberum Buy → Hold
Apr-04-18Upgrade Exane BNP Paribas Neutral → Outperform
Mar-22-18Upgrade Morgan Stanley Underweight → Equal-Weight
Feb-09-18Upgrade Kepler Reduce → Hold
Nov-06-17Downgrade Investec Buy → Hold
Oct-26-17Downgrade BofA/Merrill Buy → Neutral
Sep-08-17Downgrade Morgan Stanley Equal-Weight → Underweight
Jul-05-17Downgrade Citigroup Buy → Neutral
May-26-17Upgrade Berenberg Hold → Buy
Apr-05-17Upgrade Exane BNP Paribas Underperform → Neutral
Mar-09-17Initiated Liberum Buy
Mar-09-17Initiated Kepler Reduce
Oct-20-16Initiated Investec Buy
Sep-23-16Initiated Piper Jaffray Overweight
Jul-14-16Upgrade Jefferies Hold → Buy
Mar-30-16Upgrade Citigroup Neutral → Buy
Feb-26-16Initiated Cantor Fitzgerald Hold
Dec-09-15Upgrade BofA/Merrill Neutral → Buy
Dec-07-15Reiterated Argus Buy $52 → $48
Nov-16-18 03:48PM  Edited Transcript of GSK.L earnings conference call or presentation 31-Oct-18 2:30pm GMT Thomson Reuters StreetEvents
08:31AM  AstraZeneca Shows It Can Still Take Some Knocks Bloomberg
Nov-15-18 10:01AM  Merck's Keytruda Improves Survival in Esophageal Cancer Study Zacks
09:30AM  Has GlaxoSmithKline plc (GSK) Outpaced Other Medical Stocks This Year? Zacks
09:00AM  Harvard Researcher's Startup Offers Genome Analysis for Free Bloomberg
Nov-14-18 11:36PM  [$$] Business horrified by UK political turmoil over Brexit Financial Times
08:24AM  GSK's Triangle nonprofit awards hit $4M after 10 years American City Business Journals
06:03AM  Is GlaxoSmithKline (GSK) Right for Your Dividend Portfolio? Insider Monkey
Nov-13-18 09:22AM  Glaxo/Innoviva's Trelegy Ellipta Gets Line Extension in Europe Zacks
06:31AM  Better Buy: AbbVie Inc. vs. GlaxoSmithKline PLC Motley Fool
Nov-12-18 09:44AM  Merck's (MRK) Keytruda Gets FDA Approval for Liver Cancer Zacks
Nov-09-18 07:01AM  Once-daily Trelegy Ellipta gains expanded COPD indication in Europe Business Wire
Nov-08-18 10:58AM  Theravance (TBPH) Beats on Q3 Earnings, Inks Deal for Vibativ Zacks
Nov-06-18 08:55AM  Report: Developing Opportunities within Avon Products, Sanofi, Arch Coal, GlaxoSmithKline plc, Chimera Investment, and PTC Future Expectations, Projections Moving into 2018 GlobeNewswire
07:00AM  Today's Research Reports on Trending Tickers: GlaxoSmithKline and Eli Lilly and Company ACCESSWIRE
Nov-05-18 11:01AM  IBD 50 Growth Stocks To Watch Investor's Business Daily
Nov-02-18 08:09AM  Pharma Stock Roundup: PFE, AGN Q3 Earnings, LLY, NVS Collaboration Deals in Focus Zacks
Nov-01-18 10:29AM  Glaxo (GSK) Beats on Q3 Earnings & Sales, Raises '18 View Zacks
10:23AM  Big pharma leases almost 500,000 square feet for new research center American City Business Journals
Oct-31-18 05:55PM  GlaxoSmithKline plc (GSK) Q3 Earnings Conference Call Transcript Motley Fool
04:18PM  Mylan (MYL) Q3 Earnings: Is a Disappointment in the Cards? Zacks
02:39PM  Glaxo: 3Q Earnings Snapshot Associated Press
11:53AM  GSK feels shingles vaccine boost, but shares slip on drugs mix Reuters
11:30AM  [$$] Glaxo's Shingles Vaccine Gave Earnings a Shot in the Arm The Wall Street Journal
10:14AM  Shingles vaccine helps GSK beat earnings forecasts, raise guidance Reuters
10:00AM  Shingles vaccine helps GSK beat earnings forecasts, raise guidance Reuters
09:19AM  Glaxo (GSK) Beats Earnings Estimates in Q3, Revenue In-line Zacks
08:43AM  [$$] GSKs shingles vaccine helps it shrug off Advair fears Financial Times
08:37AM  [$$] GlaxoSmithKline 3Q Profit Rose, Raises Guidance The Wall Street Journal
Oct-30-18 12:49PM  Long-lasting HIV injection is a step closer after second GSK study Reuters
Oct-26-18 11:17AM  What's in the Cards for Glaxo (GSK) This Earnings Season? Zacks
Oct-25-18 08:53AM  3 Beaten-Down Biotech Stocks: Can They Bounce Back? Motley Fool
Oct-23-18 09:56AM  Leaning on tech expertise, Peninsula gene-editing company raises $110 million, targets lower-priced drugs American City Business Journals
Oct-22-18 11:32AM  Apple named best private sector employer in the UK CNBC
08:47AM  Merck (MRK) to Report Q3 Earnings: What's in the Cards? Zacks
08:00AM  Today's Research Reports on Trending Tickers: Immunomedics and GlaxoSmithKline ACCESSWIRE
Oct-18-18 12:24PM  Better Buy: GlaxoSmithKline plc vs. Eli Lilly Motley Fool
Oct-17-18 07:00AM  NeuroMetrix Reports Q3 2018 Financial Results GlobeNewswire
Oct-15-18 06:04PM  Trump administration: Drug makers should disclose prices in TV ads Yahoo Finance
Oct-08-18 02:50PM  Meet the $172.5 million biotech IPO from the U.K. with big plans to grow in the Bay Area American City Business Journals
Oct-05-18 05:20PM  Meet the $172.5 million biotech IPO from the U.K. with big plans to grow in the Bay Area American City Business Journals
04:42PM  Merck Reports Positive Efficacy Data from Phase III HIV Study Zacks
09:55AM  Gilead Announces Positive Data From Ongoing Biktarvy Study Zacks
Oct-04-18 09:37AM  J&J's Phase III Data Shows Switch to its HIV Drug Beneficial Zacks
Oct-03-18 07:19PM  [$$] Boston Pharma Adds to War Chest in Pacts With Novartis, GlaxoSmithKline The Wall Street Journal
12:33PM  6 of the Best Dividend Stocks Outside the U.S. InvestorPlace
11:26AM  Why Dynavax Technologies Corporation Stock Struggled in September Motley Fool
12:20AM  [$$] Nobel chemistry prize given for work that harnessed evolution Financial Times
Oct-02-18 10:18AM  GSK resumes some doctor payments, backtracking on blanket ban Reuters
Sep-28-18 10:07AM  Pharma Stock Roundup: PFE, LLY Get Approval for New Drugs, Novartis to Cut Jobs Zacks
Sep-27-18 09:03AM  Big Pharma Players on Strong Footing Ahead of Q4: 4 Picks Zacks
Sep-26-18 11:14AM  Glaxo's Tuberculosis Vaccine Positive in Mid-Stage Study Zacks
11:10AM  Theravance Up as CHMP Backs Trelegy Elipta Line Extension Zacks
08:50AM  New Research Coverage Highlights Sanofi, Amdocs, GlaxoSmithKline plc, BT Group, Sociedad Quimica y Minera S.A, and ARMOUR Residential REIT Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Sep-25-18 09:30AM  Is GlaxoSmithKline plc (GSK) Stock Outpacing Its Medical Peers This Year? Zacks
Sep-24-18 01:40PM  5 Stocks Jeremy Grantham Keeps Buying
Sep-20-18 10:48AM  Top Research Reports for Wells Fargo, Schlumberger & Biogen Zacks
Sep-19-18 10:46AM  AstraZeneca's Fasenra Long-Term Asthma Study Data Positive Zacks
09:35AM  Should Value Investors Consider Glaxo (GSK) Stock Now? Zacks
Sep-18-18 07:57PM  PRESS DIGEST- Financial Times - Sept 19 Reuters
06:36PM  Theravance, Mylan Report Positive Data on COPD Drug Yupelri Zacks
03:15PM  Exclusive: Nestle, Unilever, Coke make bids in $4 billion-plus GSK India sale - sources Reuters
12:34PM  GSK grabs new drug development head from Boehringer Reuters
05:57AM  [$$] Nestlé, Unilever and Coca-Cola bid for GSKs Horlicks unit Financial Times
Sep-17-18 06:30PM  Glaxo Seeks EU Approval for Two-Drug Regimen in First-Line HIV Zacks
08:19AM  Is Artificial Intelligence the Next Big Thing in Biotech? Zacks
Sep-14-18 04:56PM  Chinese scientist pleads guilty in plot to steal GSK secrets Associated Press
10:02AM  Pharma Stock Roundup: AZN's Leukemia Drug Wins FDA Nod, MRK's Keytruda in Focus Zacks
Sep-13-18 06:31AM  What's Next for Gilead Sciences After Its Latest Clinical Success Motley Fool
Sep-12-18 11:25AM  The Outlook for AstraZeneca Is Positive, But Its Too Early to Pull the Trigger InvestorPlace
Sep-11-18 07:35AM  Coca-Cola May Have a New Target in Its Race for Global Beverage Dominance Motley Fool
Sep-10-18 10:19AM  Glaxo's Nucala Suffers Regulatory Setback, Gets CRL for COPD Zacks
Sep-09-18 07:33AM  3 Top Value Stocks to Buy in September Motley Fool
04:33AM  Coca-Cola Plans to Bid for GSK's Horlicks: Sunday Telegraph Bloomberg
Sep-07-18 06:24PM  GSK says U.S. FDA wants more information on pulmonary drug Reuters
06:17PM  GSK says U.S. FDA wants more information on pulmonary drug Reuters
09:36AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
07:55AM  The Daily Biotech Pulse: Amgen-AstraZeneca, Boston Scientific Opens Wallet, Advaxis Offering Benzinga
Sep-06-18 07:42AM  Stocks making the biggest move premarket: CBS, XOM, FB, DAL, NAV & more CNBC
01:24AM  Drugmaker GSK to eliminate 650 U.S. jobs Reuters
12:11AM  Decoding the DNA Opportunity with Anne Wojcicki (23andMe) | Disrupt SF 2018 Yahoo Finance Video
Sep-05-18 09:13PM  Glaxo to cut 650 U.S. jobs as part of global restructuring: report MarketWatch
06:19PM  Drugmaker GSK to eliminate 650 U.S. jobs Reuters
05:58PM  23andMe CEO Anne Wojcicki on Glaxo Partnership and Data Security Bloomberg Video
05:57PM  23andMe CEO Anne Wojcicki on Glaxo Partnership and Data Security Bloomberg
05:41PM  23andMe underscores that privacy-loving customers need to opt out of its data deal with GlaxoSmithKline TechCrunch
05:05PM  GlaxoSmithKline cuts 650 jobs across the nation, 100 in RTP American City Business Journals
04:30PM  GlaxoSmithKline cuts 650 jobs across the nation, 100 in RTP American City Business Journals
10:39AM  Merck's Keytruda Gets Priority Review for Rare Skin Cancer Zacks
Sep-04-18 05:17PM  Insurance tactic drags down U.S. drug prices in 2nd qtr -analyst Reuters
03:01PM  Insurance tactic drags down U.S. drug prices in 2nd quarter -analyst Reuters
Sep-03-18 09:40AM  AstraZeneca's Lupus Drug Misses Primary Endpoint in Study Zacks
Sep-02-18 09:41AM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings Benzinga
Aug-31-18 03:53PM  Merck (MRK) Receives FDA Approval for Two HIV Medicines Zacks
03:06PM  Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates Benzinga
03:00PM  Researcher admits plot to steal GSK secrets to sell in China Associated Press
03:00PM  Researcher admits plot to steal GSK secrets to sell in China Associated Press
11:42AM  Glaxo's Asthma Drug Gets EU Nod for Pediatric Population Zacks
Aug-29-18 09:43AM  Novartis' Tafinlar/Mekinist Combo Gets EU Nod for 3rd Disease Zacks
Aug-28-18 12:00AM  [$$] Big pharma takes a gamble on NHS experiment Financial Times
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, and HIV, as well as vaccines. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Otrivin, Panadol, Fenistil, Lamisil, Breathe Right, Stiefel, Excedrin, Physiogel, Polident, parodontax, Poligrip, Sensodyne, Theraflu, and Voltaren brand names. The company offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, syrups, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and topical creams and non-medicated patches, as well as toothpastes, toothbrushes, mouth rinses, medicated mouthwashes, gels and sprays, denture adhesives, and denture cleansers. It has a discovery collaboration agreement with Kymera Therapeutics LLC; a collaboration agreement with InSysBio LLC to develop quantitative systems pharmacology model of asthma; and a strategic collaboration with NeuroMetrix, Inc. to develop and market Quell technology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLCFormer 10% holderJul 30Buy11.00148,8181,636,998624,422Aug 01 06:32 PM
GLAXOSMITHKLINE PLC10% OwnerJul 17Buy12.5080,0001,000,0001,934,006Jul 17 05:01 PM
GLAXOSMITHKLINE PLC10% OwnerJul 02Buy13.00269,2303,499,9903,697,912Jul 03 05:59 PM